Search Results

Discovery of Selective Probes and Antagonists for G Protein-Coupled Receptors FPR/FPRL1 and GPR30

Authors: Arterburn, Jeffrey B.; Oprea, Tudor I.; Prossnitz, Eric R.; Edwards, Bruce S.; Sklar, Larry A.

Source: Current Topics in Medicinal Chemistry, Volume 9, Number 13, September 2009 , pp. 1227-1236(10)

Publisher: Bentham Science Publishers

Molecular Determinants of Fluoroquinolone Antibacterial Agents Pharmacokinetics

Authors: Leveque, Dominique; Jehl, Francois

Source: Current Clinical Pharmacology, Volume 4, Number 3, September 2009 , pp. 191-197(7)

Publisher: Bentham Science Publishers

Clinical overview on Lipoplatin^™: a successful liposomal formulation of cisplatin

Author: Boulikas, Teni

Source: Expert Opinion on Investigational Drugs, Volume 18, Number 8, August 2009 , pp. 1197-1218(22)

Publisher: Informa Healthcare

Market Exclusivity Strategies for Pharmaceuticals

Author: Luchetti, Cynthia

Source: Pharmaceutical Medicine, Volume 23, Number 2, 2 April 2009 , pp. 77-84(8)

Publisher: Adis International

Activation of CAR and PXR by Dietary, Environmental and Occupational Chemicals Alters Drug Metabolism, Intermediary Metabolism, and Cell Proliferation

Authors: Hernandez, J. P.; Mota, L. C.; Baldwin, W. S.

Source: Current Pharmacogenomics and Personalized Medicine (Formerly Current Pharmacog, Volume 7, Number 2, June 2009 , pp. 81-105(25)

Publisher: Bentham Science Publishers

How did uncommon disorders become `rare diseases'? History of a boundary object

Author: Huyard, Caroline

Source: Sociology of Health & Illness, Volume 31, Number 4, May 2009 , pp. 463-477(15)

Publisher: Blackwell Publishing

Orphan drug development is not taking off

Authors: Joppi, Roberta; Bertele, Vittorio; Garattini, Silvio

Source: British Journal of Clinical Pharmacology, Volume 67, Number 5, May 2009 , pp. 494-502(9)

Publisher: Blackwell Publishing

Adopting an Orphan Drug: Rufinamide for Lennox-Gastaut Syndrome

Source: Epilepsy Currents, Volume 9, Number 3, May/June 2009 , pp. 72-74(3)

Publisher: Blackwell Publishing

European pharmaceutical pricing and reimbursement conference

Authors: Ehreth, Jenifer; Williams, Deborah

Source: Expert Review of Pharmacoeconomics and Outcomes Research, Volume 9, Number 1, February 2009 , pp. 37-39(3)

Publisher: Expert Reviews

Editorial

Author: Zaenker, Kurt S.

Source: Inflammation & Allergy - Drug Targets (Formerly Current Drug Targets - Inflammation & Allergy), Volume 8, Number 1, March 2009 , pp. 1-1(1)

Publisher: Bentham Science Publishers

Pregnane X Receptor and its Potential Role in Drug Resistance in Cancer Treatment

Authors: Chen, Yakun; Nie, Daotai

Source: Recent Patents on Anti-Cancer Drug Discovery, Volume 4, Number 1, January 2009 , pp. 19-27(9)

Publisher: Bentham Science Publishers

Thalidomide: Mechanisms of Action

Authors: Paravar, Taraneh; Lee, Delphine

Source: International Reviews of Immunology, Volume 27, Number 3, May 2008 , pp. 111-135(25)

Publisher: Informa Healthcare

US FDA grants orphan drug status to pralatrexate.

Source: Inpharma, Volume 1, Number 1667, 2008-12-06 , pp. 21-21(1)

Publisher: Adis International

Beclometasone formulation granted orphan drug status in Australia

Source: Inpharma, Volume 1, Number 1667, 2008-12-06 , pp. 21-21(1)

Publisher: Adis International

New orphan drug designated for haemophilia B.

Source: Inpharma, Volume 1, Number 1667, 2008-12-06 , pp. 22-22(1)

Publisher: Adis International

Sygnis receives orphan drug designation for AX 200.

Source: Inpharma, Volume 1, Number 1665, 2008-11-22 , pp. 23-23(1)

Publisher: Adis International

The Enzymatic Basis of Drug-Drug Interactions with Systemic Triazole Antifungals

Authors: Nivoix, Yasmine; Levêque, Dominique; Herbrecht, Raoul; Koffel, Jean-Claude; Beretz, Laurence; Ubeaud-Sequier, Genevieve

Source: Clinical Pharmacokinetics, Volume 47, Number 12, 2008 , pp. 779-792(14)

Publisher: Adis International

US FDA grants orphan drug status for melphalan.

Source: Inpharma, Volume 1, Number 1666, 2008-11-29 , pp. 22-22(1)

Publisher: Adis International

Palifosfamide granted orphan drug status in EU.

Source: Inpharma, Volume 1, Number 1661, 2008-10-25 , pp. 18-18(1)

Publisher: Adis International

CDDO Me granted orphan drug designation in the US.

Source: Inpharma, Volume 1, Number 1661, 2008-10-25 , pp. 18-18(1)

Publisher: Adis International